Fairfax India Holdings Corporation: First Quarter Financial Results
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES ( Note : All d…
globenewswire.com
NVO(NVO)
NVO
Earnings in 6 days · May 6, 2026 · Before open
Signal
Bullish Setup2↑
PRICE
Prev Close
40.29
Open
41.85
Day Range41.65 – 42.86
41.65
42.86
52W Range35.12 – 81.44
35.12
81.44
15% of range
VOLUME & SIZE
Avg Volume
22.2M
FUNDAMENTALS
P/E Ratio
11.7x
Value territory
EPS (TTM)
—
Div Yield
0.01%
Beta
0.60
Low vol
Performance
1D
-2.14%5D
+0.57%1M↑
+11.79%3M
-32.09%6M
-21.57%YTD
-20.81%1Y↓
-38.17%Best: 1M (+11.79%)Worst: 1Y (-38.17%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +6% YoY · 81% gross marginValuation
CHEAP
P/E 12x vs ~20x sectorHealth
MODERATE
CR 0.8 (low) · FCF $6.52/shStrong Buy
Key MetricsTTM
Market Cap$1.21T
Revenue TTM$309.06B
Net Income TTM$102.43B
Free Cash Flow$28.99B
Gross Margin81.0%
Net Margin33.1%
Operating Margin41.3%
Return on Equity61.1%
Return on Assets18.9%
Debt / Equity0.67
Current Ratio0.80
EPS TTM$23.05
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
4 strong2 concern
70/100Liquidity
0.80Concern
Leverage
0.67Strong
Coverage
18.8xStrong
ROE
61.1%Strong
ROIC
29.5%Strong
Cash
$26.5BConcern
ANALYST COVERAGE38 analysts
BUY
▲ +6.6%upside to target
L $42.00
Med $45.00consensus
H $54.00Stock Health
Composite Score
3 of 5 signals bullish
7/10
Technicals
●
✓RSI RangeRSI 65 — Bullish momentum
Volume
●
~Volume FlowNeutral
Fundamentals
●
✓Last EarningsBeat estimates
●
✓Analyst ConsensusBuy
●
✗LiquidityCurrent Ratio 0.80 — liquidity risk
Upcoming Events
EEarnings ReportMay 1, 2026
Tomorrow
DEx-Dividend DateJul 29, 2026
In 90 days
PDividend PaymentJul 31, 2026
In 92 days
FinancialsFull statements →
Technicals
Technical SetupBULLISH
Technicals →Trend
▲ RallyDeath Cross · 50D trails 200D by 22.6%
+8.8% vs SMA 50 · -15.8% vs SMA 200
Momentum
RSI65.2Positive momentum, not extended
MACD+0.70Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$81.44+92.9%
EMA 200
$50.39+19.3%
Current
$42.22
EMA 50
$40.92-3.1%
52W Low
$35.12-16.8%
52-Week RangeNear 52-week low
$35.1215th %ile$81.44
Squeeze SetupVolume-based
No Clear SetupVolume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.
20-Day Money Flow
Acc days:1
Dist days:2
Edge:+1 dist
Volume Context
Avg Vol (50D)9.3M
Recent Vol (5D)
7.2M-23%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 15 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $308.0B $305.4B–$310.2B | — | $23.54 | — | ±1% | High14 |
FY2026(current) | $291.6B $280.8B–$314.7B | ▼ -5.3% | $21.04 | ▼ -10.6% | ±9% | High15 |
FY2027 | $304.4B $289.8B–$327.4B | ▲ +4.4% | $21.65 | ▲ +2.9% | ±10% | High15 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryNVO
Last 8Q
+7.2%avg beat
Beat 6 of 8 quartersMissed 1↑ Estimates rising+11%
Q2'24
-6%
Q3'24
+1%
Q4'24
+3%
Q1'25
—
Q2'25
+4%
Q3'25
+32%
Q4'25
+11%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →Neutral — mixed activity
90d▲ 1▼ 3
Goldman SachsBuy → Neutral
Mar 2
DOWNGRADE
NordeaHold
Feb 24
DOWNGRADE
Deutsche BankBuy → Hold
Feb 23
DOWNGRADE
JefferiesUnderperform → Hold
Feb 12
UPGRADE
HSBCBuy → Hold
Nov 24
DOWNGRADE
HSBCHold → Buy
Oct 1
UPGRADE
Morgan StanleyOverweight → Underweight
Sep 29
DOWNGRADE
BernsteinMarket Perform → Outperform
Sep 9
UPGRADE
DBS BankSell → Hold
Aug 22
UPGRADE
Exane BNP ParibasUnderperform → Neutral
Aug 13
UPGRADE
UBSNeutral
Aug 5
DOWNGRADE
HSBCHold
Jul 31
DOWNGRADE
Financials
Dividends4.30% yield
+57.2% avg annual growthAnnual Yield4.30%
Annual Div.$1.2751
Est. Annual / Share$1.28
FrequencyAnnual
Q3'22
Q1'23
Q3'23
Q1'24
Q3'24
Q1'25
Q3'25
Q1'26
Dividend per payment — last 8 periods
INSTITUTIONAL OWNERSHIP
1
OPPENHEIMER ASSET MANAGEMENT INC.
836K▲2
TRUIST FINANCIAL CORP
811K▲3
XXEC, Inc.
545K▲4
Pictet Asset Management Holding SA
484K▲5
abrdn plc
482K▼6
NICHOLS & PRATT ADVISERS LLP /MA
480K▼7
SG Americas Securities, LLC
472K▼8
GuoLine Advisory Pte Ltd
427K—News & Activity
NVO News
20 articles · 4h ago
Fairfax Financial Holdings Limited: Financial Results for the First Quarter
globenewswire.com
Prysmian S.p.A. (PRYMY) Q1 2026 Earnings Call Transcript
seekingalpha.com
ProPetro Holding Corp. (PUMP) Q1 2026 Earnings Call Transcript
seekingalpha.com
Linamar Corporation Completes Previously Announced Acquisition of WinningBLW's Remscheid and Penzberg Facilities
globenewswire.com
HYTN Successfully Exports GMP-Manufactured Vape Cartridges
globenewswire.com
Mattr Announces Amendment to Director Nominee Slate for Its Annual Meeting
globenewswire.com
Trisura Announces Timing of First Quarter Results Release and Earnings Conference Call
globenewswire.com
Sun Life reaches settlement in principle to resolve class action
prnewswire.com
Vista Gold Announces First Quarter 2026 Financial Results
businesswire.com
EARNINGS ALERT: WDC, RDDT
youtube.com
AGNICO EAGLE REPORTS FIRST QUARTER 2026 RESULTS, INCLUDING RECORD QUARTERLY OPERATING MARGINS AND ADJUSTED NET INCOME
prnewswire.com
Edison Lithium Provides Update on Proposed Acquisition of Joutel North-West and Gagne Gold Properties
newsfilecorp.com
FARADAY FUTURE to Present at The Market Movers Investor Summit
newsfilecorp.com
AQST Deadline: ROSEN, National Trial Lawyers, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST
newsfilecorp.com
Swiss Water Conference Call Notification for 2026 First Quarter Results
globenewswire.com
Pioneer to Participate in the D. Boral Capital Global Conference 2026
newsfilecorp.com
Banco de Chile Announces Annual Report Form 20-F 2025
accessnewswire.com
Kinross announces Annual Shareholder Meeting voting results
globenewswire.com
ExGen Signs Purchase Agreement to Acquire Lithium Properties in Nevada
globenewswire.com
About
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Lars Fruergaard Joergensen
Country
Denmark
Website
Elin JagerSVP, Chief of Staff to CEO, Corporate Strategy & Sustainability and Member of Management Board
Jacob Martin Wiborg RodeVice President of Investor Relations
Jamey MillarExecutive Vice President of US Operations & Member of Management Board
Peers— —(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
NVO◀ | $42.22 | -2.14% | $179.1B | 11.1 | +642.6% | 3314.3% | 1500 |
| $396.06 | +0.42% | $2.0T | 29.3 | +3296.8% | 4510.0% | 1500 | |
| $91.86 | -0.77% | $309.3B | 13.7 | +318.8% | 1510.7% | 1500 | |
| $131.91 | -0.31% | $302.8B | 23.4 | +586.3% | 1305.9% | 1500 | |
| $187.37 | -0.82% | $287.1B | 27.6 | +862.9% | 1745.9% | 1500 | |
| $147.85 | -1.76% | $272.7B | 20.3 | +597.3% | 2564.4% | 1500 | |
| $90.67 | +1.51% | $251.7B | 14.2 | -591.0% | 668.4% | 1500 | |
| Sector avg | — | -0.55% | — | 19.9 | +816.2% | 2231.4% | 1500 |